EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population‐Based Cohort Study

Frederieke A J Gigase iD, Myrthe M G B M Boekhorst, Anna Suleri, Anna-Sophie Rommel, Michael Breen, Ryan L Muetzel, Manon H J Hillegers, Michal A Elovitz, Eric A P Steegers, Lot D De Witte, Veerle Bergink

BJOG: An International Journal of Obstetrics & Gynaecology · 2025

DOI: 10.1111/1471-0528.18191 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Frederieke A J Gigase und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Premature Birth, Cytokines, Pregnancy Complications. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Maternal immune activation has been proposed as a mechanism for adverse pregnancy outcomes, yet the mechanisms and effects of timing remain unclear. Immune disruption in early gestation may be particularly detrimental as this is an important period for placental development, which has been associated with the pathology of adverse obstetric outcomes. To increase our understanding of risk factors for adverse obstetric outcomes, we aim to investigate the association between multiple inflammatory and angiogenic markers during early pregnancy and adverse pregnancy outcomes in a large population‐based cohort.

Design

Prospective population‐based pregnancy cohort study ( n = 7513).

Setting

Rotterdam, the Netherlands. Population Pregnant women in Rotterdam between April 2002 and January 2006.

Methods

Serum inflammatory markers (high‐sensitivity (HS)‐C‐reactive protein (CRP), interleukin (IL)‐1β, IL‐6, IL‐17a, IL‐23, interferon (IFN)‐ γ ) and angiogenic factors (sFlt‐1 and PlGF) were analysed in repeated measures around 13–20 weeks gestation. A cytokine index was created using principal component analysis. Main Outcome Measures Hypertensive disorders of pregnancy, spontaneous preterm birth and small for gestational age at birth.

Results

HS‐CRP, but not the cytokine index, was associated with increased risk of spontaneous preterm birth after multiple testing correction. We found no association of HS‐CRP or the cytokine index with hypertensive disorders of pregnancy and small for gestational age at birth after multiple testing correction. Inflammatory and angiogenic factors were associated with each other, yet effect sizes were small.

Conclusions

We found no strong evidence of a link between early gestation typical inflammatory marker levels and the risk of adverse pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthCytokinesPregnancy ComplicationsHumansFemalePregnancyAdultBiomarkersPregnancy OutcomeProspective StudiesInfant, Small for Gestational AgeNetherlandsC-Reactive ProteinPlacenta Growth FactorHypertension, Pregnancy-InducedVascular Endothelial Growth Factor Receptor-1Infant, NewbornPregnancy ProteinsRisk Factors

Stichwörter der Autor:innen

CRPcytokinesmaternal immune activationpreterm birthpre‐eclampsia

Substanzen

BiomarkersC-Reactive ProteinPlacenta Growth FactorCytokinesVascular Endothelial Growth Factor Receptor-1Pregnancy ProteinsPGF protein, human

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • The Generation R Study Group, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands.
  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.

ORCID-Profile: Frederieke A J Gigase

Förderung

  • NIMH NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gigase, F. A. J., Boekhorst, M. M. G. B. M., Suleri, A., Rommel, A. S., Breen, M., Muetzel, R. L., Hillegers, M. H. J., Elovitz, M. A., Steegers, E. A. P., De Witte, L. D., & Bergink, V. (2025). Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population‐Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18191

Vancouver

Gigase FAJ, Boekhorst MMGBM, Suleri A, Rommel AS, Breen M, Muetzel RL, et al. Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population‐Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.18191

BibTeX
@article{Gigase2025,
  author = {Gigase, Frederieke A J and Boekhorst, Myrthe M G B M and Suleri, Anna and Rommel, Anna-Sophie and Breen, Michael and Muetzel, Ryan L and Hillegers, Manon H J and Elovitz, Michal A and Steegers, Eric A P and De Witte, Lot D and Bergink, Veerle},
  title = {Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population‐Based Cohort Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2025},
  doi = {10.1111/1471-0528.18191}
}
Kostenlos starten →